Chronic Kidney Disease News

Unintended pregnancy after kidney transplantation was not linked to perinatal acute allograft rejection but was associated with mycophenolate exposure and allograft loss at 2 years postpartum, according to data published in O&G Open.

CHICAGO — A potassium binder helped patients with HF who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk, researchers reported.

Older women with chronic kidney disease who take denosumab may have a higher risk for emergently treated hypocalcemia compared with those treated with bisphosphonates, according to published data.

The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, but it could also lead to changes in the way clinicians treat the condition.

SAN DIEGO — A quality improvement project among a predominately Black urban population helped patients on hemodialysis who were involuntary discharged regain access to care, according to presented data.

In this video exclusive, Deidra C. Crews, MD, ScM, FASN, president of the American Society of Nephrology discusses connections between kidney disease and obesity.

SAN DIEGO — Adults with end-stage kidney disease on long-term hemodialysis may be confronted with complex medication regimens after hospitalizations, data presented at ASN Kidney Week show.

SAN DIEGO — Pain coping skills training may be beneficial for pain interference and related outcomes for patients on hemodialysis, according to data presented at ASN Kidney Week.

Effective Jan. 1, 2025, CMS will begin including phosphate-binders in the end-stage renal disease prospective payment system bundle.